血清S100β度增加与帕金森病中的抑郁症有关
Guanghui Jiang1, Cuicui Sheng1, Luxia Yan1
1Department of Neurology, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, People's Republic of China.
Neuropsychiatric disease and treatment
|September 4, 2023
概括
血清S100结合蛋白β链 (S100β) 水平在患有抑郁症的帕金森病 (PD) 患者中升高. 较高的S100β可能作为PD与抑郁症的生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 临床医学 临床医学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,经常伴有抑郁症.
- 确定可靠的PD与抑郁症的生物标志物对于诊断和管理至关重要.
研究的目的:
- 研究S100结合蛋白,β链 (S100β) 的血清水平与帕金森病患者抑郁症的存在和严重程度之间的关联.
- 评估血清S100β作为PD与抑郁症的生物标志物的诊断潜力.
主要方法:
- 在145名PD患者和60名对照人群中,用光定量免疫染色学量化了血清S100β水平.
- 临床评估包括统一的帕金森病评分表第三部分 (UPDRS-III),霍恩和雅赫 (H-Y) 阶段,以及17项的抑郁症汉密尔顿评分表 (HAMD-17).
- 进行了相关性和多变量回归分析,以及接收器操作特征 (ROC) 曲线分析.
主要成果:
- 在患有抑郁症的PD患者中,血清S100β水平明显高于没有抑郁症和健康对照患者.
- 在患有抑郁症的PD患者中,血清S100β水平与UPDRS-III,H-Y阶段和HAMD-17得分正相关.
- 血清S100β和UPDRS-III得分的升高被确定为PD与抑郁症的独立风险因素. 根据ROC分析,S100β具有诊断价值 (AUC=0.742).
结论:
- 血清S100β可以作为一种潜在的生物标志物,用于识别与抑郁症相关的帕金森病.
- 这些发现表明S100β与PD抑郁症的病理生理学之间存在联系.
更多相关视频
09:27Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
17.4K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.9K
相关概念视频
Parkinson's Disease: Overview
593
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
593
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Depression: Overview
274
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
274
